Atlas Trials

The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer

Clinical trial NCT01000428 · UNKNOWN

Trial details

NCT number
NCT01000428
Sponsor
Asan Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
ErlotinibLung Cancer
Start date
2009-06-01
Primary completion
2010-05-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.